CM Management’s Elicio Therapeutics ELTX Stock Holding History

CM Management’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,000	Closed	-$267K	–	76
2026 Q1	$267K	Hold	25,000	–	–	0.22%	69
2025 Q4	$199K	Buy	25,000 +19,000	+317%	+$172K	0.17%	61
2025 Q3	$65.6K	Sell	6,000 -19,000	-76%	-$192K	0.05%	65
2025 Q2	$193K	Sell	25,000 -30,000	-55%	-$187K	0.18%	66
2025 Q1	$339K	Buy	55,000 +15,000	+38%	+$116K	0.34%	49
2024 Q4	$204K	Sell	40,000 -10,000	-20%	-$49.2K	0.18%	54
2024 Q3	$252K	Hold	50,000	–	–	0.2%	61
2024 Q2	$206K	Sell	50,000 -25,000	-33%	-$211K	0.19%	61
2024 Q1	$570K	Buy	75,000 +25,000	+50%	+$125K	0.48%	55
2023 Q4	$417K	Sell	50,000 -15,000	-23%	-$97.8K	0.34%	61
2023 Q3	$549K	Hold	65,000	–	–	0.58%	47
2023 Q2	$618K	Sell	65,000 -15,000	-19%	-$138K	0.6%	48
2023 Q1	$464K	Buy	80,000 +6,782	+9%	+$45.2K	0.55%	46
2022 Q4	$594K	Buy	73,218 +13,218	+22%	+$120K	0.71%	48
2022 Q3	$552K	Buy	60,000 +7,500	+14%	+$78.4K	0.62%	53
2022 Q2	$599K	Buy	52,500 +7,500	+17%	+$120K	0.64%	49
2022 Q1	$954K	Buy	45,000 +33,822	+303%	+$764K	0.8%	44
2021 Q4	$324K	Buy	11,178 +1,803	+19%	+$91.2K	0.24%	81
2021 Q3	$916K	Hold	9,375	–	–	0.68%	54
2021 Q2	$1.22M	Hold	9,375	–	–	0.88%	43
2021 Q1	$1.69M	Buy	+9,375	New	+$1.81M	1.26%	24

Other funds holding ELTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CM Management's ELTX Position: Q2 2026 in Review

CM Management sold out of Elicio Therapeutics (ELTX) in Q2 2026, closing a stake of 25,000 shares — an estimated $267K sold.

CM Management first reported a position in ELTX in Q1 2021 and held it in 21 quarters. The position peaked at $1.69M in Q1 2021. 46 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

CM Management reported no remaining Elicio Therapeutics position as of Q2 2026 after selling out during the quarter.
CM Management sold 25,000 Elicio Therapeutics shares in Q2 2026, an estimated $267K.
CM Management first reported a position in Elicio Therapeutics in Q1 2021 and held it in 21 quarters.
CM Management's Elicio Therapeutics position peaked at $1.69M in Q1 2021.
46 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.